Subtle brain dysfunction in treated 6-pyruvoyl-tetrahydropterin synthase deficiency: relationship to motor tasks and neurophysiological tests.
6-Pyruvoyl-tetrahydropterin synthase (6PTPS) deficiency is a major cause of biopterin deficiency. 6PTPS patients usually have an elevated serum phenylalanine level, a deficiency of neurotransmitters (serotonin and dopamine), and neurological symptoms, if without treatment. We herein investigated the possibility of neurological dysfunction in early-treated patients. In the study, 12 early-treated 6PTPS patients were studied. Their auditory simple reaction time, movement rhythm variation (MRV), somatosensory evoked potentials to median nerve stimulation, and hand muscle responses to transcranial magnetic stimulation, were measured. MRV is a test of repetitive voluntary movements, and was used with and without auditory cues at 0.3 Hz. The 6PTPS patients had an increased motor threshold but normal motor and sensory central conduction times. They performed very well in simple reactions (6PTPS 208.4+/-16.7 ms, control 200.3+/-11.7 ms, p=0.18), but not in continuous tasks. The continuous performance tests showed that MRV had increased in the 6PTPS patients (with cues: 6PTPS 7.35+/-0.94, control 5.47+/-0.80, p<0.0001; without cues: 6PTPS 9.87+/-1.44, control 6.59+/-0.68, p<0.0001). Without cues, MRV had increased in both the 6PTPS and control groups, but more significantly in the 6PTPS patients (6PTPS 2.51+/-0.97, control 1.25+/-0.42; p=0.0001). Our findings indicate that early-treated 6PTPS patients have subtle neurological dysfunctions. They may not maintain movement rhythm as well as normal subjects, even with external cues. Hence, MRV is a good method to assess motor control.
Kao
Chuen-Der
CD
Neurological Institutes, Taipei Veterans General Hospital, Taipei 11217, Taiwan, ROC.
Niu
Dau-Ming
DM
Chen
Jen-Tse
JT
Shan
Din-E
DE
Lin
Yung-Yang
YY
Wu
Zin-An
ZA
Liao
Kwong-Kum
KK
D000161:Acoustic Stimulation; D000293:Adolescent; D001708:Biopterins / Q000096:biosynthesis / Q000172:deficiency*; D020739:Brain Diseases, Metabolic, Inborn / Q000201:enzymology / Q000503:physiopathology* / Q000523:psychology*; D002540:Cerebral Cortex / Q000201:enzymology / Q000503:physiopathology; D002648:Child; D003463:Cues; D004558:Electric Stimulation; D004574:Electromagnetic Fields; D004594:Electrophysiology; D005073:Evoked Potentials, Somatosensory / Q000502:physiology; D005260:Female; D006801:Humans; D008280:Magnetics; D008297:Male; D009069:Movement Disorders / Q000201:enzymology / Q000503:physiopathology* / Q000523:psychology*; D019761:Phosphorus-Oxygen Lyases / Q000172:deficiency*; D011930:Reaction Time / Q000502:physiology
D001708:Biopterins; D019761:Phosphorus-Oxygen Lyases; C043497:6-pyruvoyltetrahydropterin synthase